The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison of Three Different Guidelines for Osteoporosis Treatment in Patients with Rheumatoid Arthritis in Korea

  • Yoon, Ji-Yeol (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Kwon, Seong-Ryul (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Lim, Mie-Jin (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Joo, Ko-Woon (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Moon, Chang-Gi (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Jang, Ji-Hun (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine) ;
  • Park, Won (Division of Rheumatology, Department of Internal Medicine, Inha University College of Medicine)
  • Received : 2010.06.27
  • Accepted : 2010.08.26
  • Published : 2010.12.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Osteoporotic fractures are an important comorbidity with rheumatoid arthritis (RA). We determined the overall fracture risk as assessed by the World Health Organization (WHO)'s $FRAX^{(R)}$ tool in Korean patients with seropositive RA. Additionally, we compared treatment eligibility according to the criteria of the Korean Health Insurance Review Agency (HIRA), FRAX, and the National Osteoporosis Foundation (NOF). Methods: Postmenopausal women and men ${\geq}$ 50 years of age with seropositive RA were recruited from one rheumatism center in Korea. The FRAX score was estimated using the Japanese model. Patients were classified as eligible for treatment using the HIRA, NOF, and FRAX thresholds for intervention. Results: The study of 234 patients included 40 men (17%). The mean age was $60{\pm}9$ years, and 121 (52%) patients had osteoporosis according to the WHO criteria. The overall median 10-year fracture risk was 13% for major osteoporotic fractures and 3.5% for hip fractures. HIRA guidelines identified 130 patients (56%) eligible for treatment, FRAX included 126 patients (54%), and 151 patients (65%) were included according to NOF guidelines. Older patients with a greater number of risk factors were included by FRAX compared to HIRA. The overall concordance between HIRA and FRAX, expressed as the kappa index, was 0.67, but was as low as 0.44 when limited to patients ${\geq}$ 60 years of age. Conclusions: One-half of the patients had osteoporosis requiring treatment. RA patients have a high risk of fracture, and the adoption of a risk-scoring system should be considered.

Keywords

References

  1. Sinigaglia L, Nervetti A, Mela Q, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000;27:2582-2589.
  2. Sinigaglia L, Varenna M, Girasole G, Bianchi G. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006;32:631-658. https://doi.org/10.1016/j.rdc.2006.07.002
  3. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int 2005;16:581-589. https://doi.org/10.1007/s00198-004-1780-5
  4. Korean Health Insurance Review Agency. General Guideline of Pharmacologic Intervention For Osteoporosis [Internet]. Seoul (KR): Health Insurance Review Agency, c2010 [cited 2010 May 20]. Available from: http://www.hira.or.kr.
  5. Baim S, Binkley N, Bilezikian JP, et al. Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom 2008;11:75-91. https://doi.org/10.1016/j.jocd.2007.12.007
  6. Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX:assessment and intervention thresholds for the UK. Osteoporos Int 2008;19:1395-1408. https://doi.org/10.1007/s00198-008-0712-1
  7. World Health Organization. FRAX WHO Fracture Risk Assessment Tool. V3.0 [Internet]. Geneva: World Health Organization, c2009 [cited 2010 Mar 20]. Available from: http://www.shef.ac.uk/FRAX/index.htm.
  8. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis [Internet]. Washington (DC): National Osteoporosis Foundation, c2010 [cited 2010 Mar 20]. Available from: http://www.nof.org.
  9. Orimo H, Sugioka Y, Fukunaga M, et al. Diagnostic criteria for primary osteoporosis. J Bone Miner Metab 1998;16:139-150. https://doi.org/10.1007/s007740050038
  10. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1-129.
  11. May WL, Johnson WD. The validity and power of tests for equality of two correlated proportions. Stat Med 1997;16:1081-1096. https://doi.org/10.1002/(SICI)1097-0258(19970530)16:10<1081::AID-SIM521>3.0.CO;2-X
  12. Joo YS, Lee SS, Kim WU, et al. Generalized osteoporosis in Korean rheumatoid arthritis patients. J Korean Rheum Assoc 2000;7:32-42.
  13. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522-530. https://doi.org/10.1002/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y
  14. Korean Ministry of Health and Welfare, Korean Centers for Disease Control and Prevention. National Health and Nutrition Survey 4th 2008 [Internet]. Seoul (KR): Korean Centers for Disease Control and Prevention, c2009 [cited 2010 May 20]. Available from: http://knhanes.cdc.go.kr.
  15. Fujiwara S, Nakamura T, Orimo H, et al. Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int 2008;19:429-435. https://doi.org/10.1007/s00198-007-0544-4
  16. World Health Organization. WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. In: WHO, Summary Meeting Report; 2004 May 5-7; Brussels, Belgium. Geneva: WHO Press, 2004.
  17. Ensrud KE, Lui LY, Taylor BC, et al. A comparison of prediction models for fractures in older women: is more better? Arch Intern Med 2009;169:2087-2094. https://doi.org/10.1001/archinternmed.2009.404
  18. Leslie WD, Tsang JF, Lix LM. Simplified system for absolute fracture risk assessment: clinical validation in Canadian women. J Bone Miner Res 2009;24:353-360. https://doi.org/10.1359/jbmr.081012
  19. Donaldson MG, Cawthon PM, Lui LY, et al. Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines. J Bone Miner Res 2009;24:675-680. https://doi.org/10.1359/jbmr.081203
  20. Kanis JA, Burlet N, Cooper C, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399-428. https://doi.org/10.1007/s00198-008-0560-z

Cited by

  1. Bone Mineral Density Changes in Patients with Recent-Onset Rheumatoid Arthritis vol.4, pp.None, 2010, https://doi.org/10.4137/cmamd.s7773
  2. Increased frequency of osteoporosis and BMD below the expected range for age among South Korean women with rheumatoid arthritis vol.15, pp.3, 2010, https://doi.org/10.1111/j.1756-185x.2012.01729.x
  3. The Risk of Osteoporotic Fractures According to the FRAX Model in Korean Patients with Rheumatoid Arthritis vol.29, pp.8, 2014, https://doi.org/10.3346/jkms.2014.29.8.1082
  4. Proper time to initiate antiosteoporotic treatment in rheumatoid arthritis with or without glucocorticoid use vol.29, pp.4, 2010, https://doi.org/10.3904/kjim.2014.29.4.434
  5. Rheumatoid arthritis patients with hip fracture: a nationwide study vol.26, pp.2, 2010, https://doi.org/10.1007/s00198-014-2968-y
  6. A systematic review of intervention thresholds based on FRAX : A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation vol.11, pp.1, 2010, https://doi.org/10.1007/s11657-016-0278-z
  7. The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis vol.17, pp.None, 2010, https://doi.org/10.1186/s12891-016-0952-8
  8. Lean Mass and Disease Activity are the Best Predictors of Bone Mineral Loss in the Premenopausal Women with Rheumatoid Arthritis vol.22, pp.2, 2010, https://doi.org/10.4103/ijem.ijem_665_17